Cue Biopharma CFO James M. Ahlers files initial beneficial ownership statement
CUE•Form 3 filing
- Cue Biopharma CFO James M. Ahlers filed an initial Form 3 statement of beneficial ownership dated July 30, 2026.
Related News
Nasdaq trade halt <ELPW.O> halt news pending at 07:50 PM
ELPW•
Nasdaq trade halt continues <SVA.O> reason not available at 03:28 AM
SVA•
UAE says Iran attacked ADNOC vessel with missile in Strait of Hormuz
XLE•
Berkshire accelerates buybacks, lowers cash stake as profit tops forecasts
BRK.A•
NASDAQ trade halt continues <LAWR.O> reason not available at 03:28 AM
LAWR•